Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;92(6):1434-1435.
doi: 10.1016/j.jaad.2025.02.031. Epub 2025 Feb 18.

Postmarketing safety surveillance of adalimumab, secukinumab, and infliximab in hidradenitis suppurativa: an analysis of the FDA adverse events reporting system (FAERS) database

Aditya Joshi  1 , Lauren Gawey  2 , Carissa Saadi  3 , Pragna Naidoo  2 , Jonathan W Rick  4 , Song Y Park  2 , Anna L Cogen  2 , Steven D Daveluy  5 , Jennifer L Hsiao  6 , Vivian Y Shi  7
Affiliations

Postmarketing safety surveillance of adalimumab, secukinumab, and infliximab in hidradenitis suppurativa: an analysis of the FDA adverse events reporting system (FAERS) database

Aditya Joshi et al. J Am Acad Dermatol. 2025 Jun.
No abstract available

Keywords: FDA adverse event reporting system (FAERS); adalimumab; adverse events; biologics; hidradenitis suppurativa; infliximab; pharmacovigilance; postmarketing surveillance; safety profiling; secukinumab.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Dr Shi is on the board of directors for the Hidradenitis Suppurativa Foundation (HSF), an advisor for the National Eczema Association, is a stock shareholder of Learn Health and has served as an advisory board member, investigator, speaker, and/or received research funding from Sanofi Genzyme, Regeneron, AbbVie, Genentech, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Pfizer, Incyte, Dermavant, Boehringer Ingelheim, Almirall, Alumis, Aristea Therapeutics, Menlo Therapeutics, Dermira, Burt’s Bees, Galderma, Kiniksa, UCB, Ceraclere, Bain Capital, Target-PharmaSolutions, Castle Bioscience, Altus Lab/cQuell, MYOR, Polyfins Technology, GpSkin and Skin Actives Scientific. Authors Joshi and Saadi and Drs Gawey, Naidoo, Rick, Park, Cogen, Daveluy, and Hsiao have no conflicts of interest to declare.

LinkOut - more resources